Benzylidene insertion reactions in organoplatinum chemistry: mechanism and selectivity. [PDF]
RSC AdvMoustafa ME, Boyle PD, Puddephatt RJ.
europepmc +1 more source
Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive Immunogenicity. [PDF]
J Am Chem SocZou JX +4 more
europepmc +1 more source
Foreword to the focus issue, 'nanoarchitectonics reloaded: method for everything in materials science'. [PDF]
Sci Technol Adv MaterAriga K.
europepmc +1 more source
In Vivo Imaging of a Photoactivatable Platinum Prodrug by Metal-Centered Radiolabeling. [PDF]
J Am Chem SocFirth G +8 more
europepmc +1 more source
Computational Analysis of Chromophore-Controlled Photoactivation in Monofunctional Platinum(II)-BODIPY Conjugates for Dual Chemo-Photodynamic Therapy. [PDF]
ChembiochemPonte F, Mazzone G.
europepmc +1 more source
Oxaliplatin and amlodipine combination induced reversible Brugada phenocopy: A case report. [PDF]
Medicine (Baltimore)Bian W, Zhang H, Liu M, Qi X, Li J.
europepmc +1 more source
HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial. [PDF]
Signal Transduct Target TherLi SH +10 more
europepmc +1 more source
Mechanistic Fingerprints from Chloride to Iodide: Halide vs. Ammonia Release in Platinum Anticancer Complexes. [PDF]
Int J Mol SciChiaverini L +14 more
europepmc +1 more source
A case of folinic acid, fluorouracil and oxaliplatin (FOLFOX) chemotherapy regimen associated neurotoxicity and review of literature. [PDF]
BMC NeurolSrivastava J +3 more
europepmc +1 more source
Durable response to FOLFOX plus serplulimab in AFP-producing gastric adenocarcinoma with liver metastases: a case report and literature review. [PDF]
Front ImmunolJin Y, Fu L, Zhao Y, Tong Z, Tan Y.
europepmc +1 more source